TQA-3729

Part I. The main purpose of the healthy subjects trial: To evaluate the safety and tolerability of multiple doses, single and multiple administrations of TQA3729 in healthy subjects. Secondary objectives: 1. To evaluate the pharmacokinetics of multiple doses, single and multiple administrations of TQA3729 in healthy subjects; 2. To evaluate the drug metabolism and transformation study of TQA3729; 3. To evaluate the effect of food on the pharmacokinetics of TQA3729. Part II. The main purpose of the hepatitis B patient trial: 1. To evaluate the safety and tolerability of TQA3729 combined with oral nucleoside (acid) drugs in patients with chronic hepatitis B who are undergoing initial treatment. Secondary objectives: 1. To evaluate the efficacy of TQA3729 combined with oral nucleoside (acid) drugs in patients with chronic hepatitis B who are undergoing initial treatment; 2. To evaluate the pharmacokinetic characteristics of TQA3729 combined with oral nucleoside (acid) drugs in patients with chronic hepatitis B who are undergoing initial treatment;